Ronald Blue Trust, Inc. Sanofi Transaction History

Ronald Blue Trust, Inc.

$8.16 Billion
Q4 2024

A detailed history of Ronald Blue Trust, Inc. transactions in Sanofi stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 21,128 shares of SNY stock, worth $1.09 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

21,128

Previous 18,046 17.08%

Holding current value

$1.09 Million

Previous $1.04 Million 2.02%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$45.89 - $57.31 $141,432 - $176,629	3,082 Added 17.08%	21,128 $1.02 Million
Q3 2024 Oct 17, 2024	BUY	$48.54 - $58.53 $210,954 - $254,371	4,346 Added 31.72%	18,046 $1.04 Million
Q2 2024 Jul 18, 2024	BUY	$45.39 - $50.36 $193,633 - $214,835	4,266 Added 45.22%	13,700 $664,000
Q1 2024 May 01, 2024	BUY	$45.75 - $52.48 $112,865 - $129,468	2,467 Added 35.41%	9,434 $458,000
Q4 2023 Jan 18, 2024	BUY	$43.13 - $54.79 $46,062 - $58,515	1,068 Added 18.1%	6,967 $374,000
Q3 2023 Oct 11, 2023	BUY	$50.95 - $55.2 $211,901 - $229,576	4,159 Added 239.02%	5,899 $318,000
Q2 2023 Jul 14, 2023	SELL	$50.45 - $57.18 $556,715 - $630,981	-11,035 Reduced 86.38%	1,740 $95,000
Q1 2023 Apr 17, 2023	BUY	$45.86 - $54.45 $298,686 - $354,632	6,513 Added 104.01%	12,775 $619,000
Q4 2022 Jan 17, 2023	BUY	$38.86 - $48.55 $134,611 - $168,177	3,464 Added 123.8%	6,262 $239,000
Q3 2022 Oct 21, 2022	BUY	$37.22 - $100.5 $79,427 - $214,467	2,134 Added 321.39%	2,798 $140,000
Q2 2022 Aug 09, 2022	BUY	$48.99 - $57.46 $32,529 - $38,153	664 New	664 $34,000

Others Institutions Holding SNY

# of Institutions

809

Shares Held

268M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $129B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.

Account

Ronald Blue Trust, Inc. Sanofi Transaction History